Literature DB >> 29080212

Targeting inflammation to reduce cardiovascular disease risk.

Pasquale Maffia1,2,3, Giuseppe Cirino3.   

Abstract

This joint themed section of the British Journal of Pharmacology and the British Journal of Clinical Pharmacology stems from a joint British Pharmacological Society - Italian Society of Pharmacology symposium held at the 37th National Congress of the Italian Society of Pharmacology in Naples (Italy) from 27 to 30 October 2015. LINKED ARTICLES: This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29080212      PMCID： PMC5659995          DOI： 10.1111/bph.14039

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  21 in total

Review 1.  Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective.

Authors:  Carlo Patrono
Journal:  Br J Clin Pharmacol       Date:  2016-07-18       Impact factor: 4.335

Review 2.  Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

Authors:  Fatima Iqbal; Wendy S Baker; Madiha I Khan; Shwetha Thukuntla; Kevin H McKinney; Nicola Abate; Demidmaa Tuvdendorj
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

3.  Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice.

Authors:  Marcelo H Petri; Andrés Laguna-Fernandez; Hildur Arnardottir; Craig E Wheelock; Mauro Perretti; Göran K Hansson; Magnus Bäck
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

4.  Targeting inflammation to reduce cardiovascular disease risk.

Authors:  Pasquale Maffia; Giuseppe Cirino
Journal:  Br J Pharmacol       Date:  2017-11       Impact factor: 8.739

Review 5.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

6.  The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

Review 7.  Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?

Authors:  Paul Welsh; Gianluca Grassia; Shani Botha; Naveed Sattar; Pasquale Maffia
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

Review 8.  T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.

Authors:  E Stephenson; K Savvatis; S A Mohiddin; F M Marelli-Berg
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

Review 9.  Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.

Authors:  Lavinia Woodward; Ioannis Akoumianakis; Charalambos Antoniades
Journal:  Br J Pharmacol       Date:  2016-10-19       Impact factor: 8.739

10.  Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.

Authors:  D S Skiba; R Nosalski; T P Mikolajczyk; M Siedlinski; F J Rios; A C Montezano; J Jawien; R Olszanecki; R Korbut; M Czesnikiewicz-Guzik; R M Touyz; T J Guzik
Journal:  Br J Pharmacol       Date:  2017-02-01       Impact factor: 8.739
View more
  5 in total

1.  Targeting inflammation to reduce cardiovascular disease risk.

Authors:  Pasquale Maffia; Giuseppe Cirino
Journal:  Br J Pharmacol       Date:  2017-11       Impact factor: 8.739

2.  Anti-inflammatory and Regulatory Effects of Huanglian Jiedu Decoction on Lipid Homeostasis and the TLR4/MyD88 Signaling Pathway in LPS-Induced Zebrafish.

Authors:  Junyi Zhou; Xinru Gu; Xiaorui Fan; Yanyan Zhou; Hongjie Wang; Nan Si; Jian Yang; Baolin Bian; Haiyu Zhao
Journal:  Front Physiol       Date:  2019-09-26       Impact factor: 4.566

3.  Association between serum 25-hydroxyvitamin d and myeloperoxidase: A cross-sectional study of a general population in China.

Authors:  Junteng Zhou; Ruicen Li; Ting Bao; Wei Jiang; Yan Huang
Journal:  Front Nutr       Date:  2022-08-02

Review 4.  Obstructive Sleep Apnea as a Cardiovascular Risk Factor-Beyond CPAP.

Authors:  Joshua M Bock; Soumya Vungarala; Shahid Karim; Virend K Somers
Journal:  Can J Cardiol       Date:  2021-02-19       Impact factor: 5.223

5.  Interleukin 10, lipid profile, vitamin D, selenium, metabolic syndrome, and serum antioxidant capacity in elderly people with and without cardiovascular disease: Amirkola health and ageing project cohort-based study.

Authors:  Hamid Reza Nematollahi; Reza Hosseini; Ali Bijani; Haleh Akhavan-Niaki; Hadi Parsian; Mahdi Pouramir; Mehrdad Saravi; Mojgan Bagherzadeh; Abbas Mosapour; Massud Saleh-Moghaddam; Majid Rajabian; Monireh Golpour; Amrollah Mostafazadeh
Journal:  ARYA Atheroscler       Date:  2019-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.